Catalyst Wire Dossier Catalyst Wire Dossier

Vosoritide

vosoritide · BioMarin Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Vosoritide, covering 2024-06-24 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia [Phase 2, Phase 3]

See pricing